首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Chronic kidney disease stage in renal transplantation classification using cystatin C and creatinine-based equations.
【24h】

Chronic kidney disease stage in renal transplantation classification using cystatin C and creatinine-based equations.

机译:使用半胱氨酸蛋白酶抑制剂C和基于肌酸酐的方程式对肾脏移植进行分类的慢性肾脏疾病阶段。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Current clinical guidelines recommend that renal transplant recipients (RTRs) be classified into chronic kidney disease (CKD) stage using a creatinine-based estimate of glomerular filtration rate (GFR). However, creatinine-based equations are inaccurate in RTRs leading to frequent CKD stage misclassification. It is not known whether the classification of CKD stage would be improved using a cystatin C-based estimate of GFR. METHODS: We measured (99m)Tc-DTPA GFR, cystatin C and creatinine in 198 stable RTRs. GFR was estimated using cystatin C-based equations (Filler, Le Bricon and Rule) and four creatinine-based equations. We determined the proportion, overall and by CKD stage, that were classified correctly by each equation as compared to the (99m)Tc-DTPA GFR. RESULTS: The Filler equation correctly classified 76% of patients compared to only 65% with the abbreviated modification of diet in renal disease (MDRD) equation and 69% with the Cockcroft-Gault equation. In CKD stages two and four, the Filler equation correctly classified 77% and 60% of patients whereas the abbreviated MDRD equation correctly classified 46% and 93% of patients. The area under the curve by receiver operating curve analysis for overall stage classification was uniformly poor for all equations (0.52-0.56). CONCLUSIONS: The cystatin C-based Filler and Le Bricon GFR estimates classified slightly more patients into the correct CKD stage than the standard creatinine-based equations in stable RTRs although the overall diagnostic accuracies were similar. The differences are modest and prospective studies will be needed to determine if the adoption of these equations for classification would lead to improved recognition of CKD complications or patient care.
机译:背景:目前的临床指南建议使用基于肌酐的肾小球滤过率(GFR)评估将肾移植受体(RTR)分为慢性肾脏疾病(CKD)期。但是,基于肌酸酐的方程式在RTR中不准确,从而导致CKD阶段错误分类频繁。使用基于半胱氨​​酸蛋白酶抑制剂C的GFR评估是否可以改善CKD分期尚不明确。方法:我们测量了198个稳定RTR中的(99m)Tc-DTPA GFR,胱抑素C和肌酐。使用基于胱抑素C的方程(Filler,Le Bricon和Rule)和四个基于肌酸酐的方程估算GFR。我们确定了与(99m)Tc-DTPA GFR相比,通过每个方程正确分类的总体比例和CKD比例。结果:Filler方程正确地对76%的患者进行了分类,相比之下,饮食中缩写形式的肾脏疾病(MDRD)方程仅为65%,而Cockcroft-Gault方程则只有69%。在CKD的第二阶段和第四阶段,Filler方程正确分类了77%和60%的患者,而缩写MDRD方程正确分类了46%和93%的患者。对于所有等式,通过接收器工作曲线分析得出的用于整个阶段分类的曲线下面积均较差(0.52-0.56)。结论:在稳定的RTR中,基于胱抑素C的Filler和Le Bricon GFR估计值比基于肌酐的标准方程式将进入正确CKD阶段的患者分类略多,尽管总体诊断准确性相似。差异不大,需要进行前瞻性研究以确定采用这些等式进行分类是否会导致对CKD并发症或患者护理的认识得到改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号